AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31881181
Drug: Insulin assay
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin assay applied in bioequivalence study of miglitol
Trial: 28276638
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid 5 mg/year
Trial: 26828618
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid 5 mg
Trial: 22305183
Drug: Oral acetylcysteine
RxNorm normalized name: Acetylcysteine
DrugBank: Acetylcysteine magnesium (DB14080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acetylcysteine (1200 mg twice daily for 2 days, starting the day before contrast exposure)
Trial: 15767218
Drug: Valproate MR
RxNorm normalized name: valproate
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproate MR granules administered once/day or twice/day (500 mg)
Trial: 15767218
Drug: Valproate MR
RxNorm normalized name: valproate
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Valproate MR granules administered with yogurt or after a high-fat meal
Trial: 15767218
Drug: Existing valproate
RxNorm normalized name: valproate
DrugBank: Valproic acid (DB00313)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Existing valproate SR formulations
Trial: 12410497
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) orally (600 mg) plus saline every 12 hr for 24 hr before and after the procedure
Trial: 12410497
Drug: Saline (0.45%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (0.45% normal saline at 1 cc/kg) for 12 hr before and 12 hr after the procedure
Trial: 10519498
Drug: Lidocaine with
RxNorm normalized name: Lidocaine with Tegaderm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine with epinephrine (2.5 microg/ml)
Trial: 6127901
Drug: Prenalterol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenalterol (20 mg in controlled release preparation)
Trial: 6127901
Drug: Prenalterol (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenalterol (intravenous dose)
Trial: 6127901
Drug: Prenalterol (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prenalterol (oral dose)
Trial: 29346837
Drug: Ertugliflozin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ertugliflozin (100 mg; supratherapeutic dose)
Trial: 29346837
Drug: Moxifloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moxifloxacin (400 mg; positive control)
Trial: 22246026
Drug: CGRP infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CGRP infusion (1.5 μg/min for 20 min)
Trial: 19439741
Drug: Standard chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard chemotherapy (cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide plus doxorubicin)
Trial: 15532079
Drug: Dornase alpha
RxNorm normalized name: Dornase alpha
DrugBank: Dornase alfa (DB00003)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dornase alpha (2.5 mg daily)
Trial: 9772947
Drug: Daflon 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daflon 500 mg (2 tablets)
Trial: 8205595
Drug: Lansoprazole and
RxNorm normalized name: Lansoprazole and naproxen only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole and amoxicillin
Trial: 364059
Drug: Doxycycline administered
RxNorm normalized name: Doxycycline
DrugBank: Doxycycline (DB00254)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Doxycycline administered before and during the first three postoperative days
Trial: 26757466
Drug: Nitinol coils
RxNorm normalized name: BOIL-EASE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitinol coils treatment
Trial: 20642548
Drug: febuxostat 80
RxNorm normalized name: febuxostat 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: febuxostat 80 mg + hydrochlorothiazide 50 mg
Trial: 12058515
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy for cognitive-perceptual abilities
Trial: 12058515
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy for motor capacities
Trial: 12164890
Drug: Oral nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nutritional supplementation during hemodialysis
Trial: 9854466
Drug: 5-hydroxytryptamine (serotonin)
DrugBank: Serotonin (DB08839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-hydroxytryptamine (serotonin) infusion at increasing doses (15 nmol.min-1.kg-1 and 60 nmol.min-1.kg-1)
Trial: 406103
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (betamethasone valerate and sodium cromoglycate)
Trial: 26479132
Drug: Daily monitoring
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily monitoring condition (n = 89)
Trial: 26479132
Drug: Daily report
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily report total cigarettes
Trial: 9466512
Drug: Candid 1,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candid 1, a live attenuated Junin virus vaccine
Trial: 365797
Drug: Chenodeoxycholic acid
RxNorm normalized name: Chenodeoxycholic acid
DrugBank: Chenodeoxycholic acid (DB06777)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chenodeoxycholic acid (CDCA), 200 mg/day for 5 days
Trial: 31670004
Drug: Standard PAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard PAP treatment (SG)
Trial: 31670004
Drug: Proactive telemonitored
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proactive telemonitored PAP treatment (TG)
Trial: 28480505
Drug: Cardamom supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardamom supplementation (3 g d-1) for 8 weeks
Trial: 22835761
Drug: Enzyme-inducing antiepileptic
RxNorm normalized name: lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enzyme-inducing antiepileptic drugs (EI-AEDs)
Trial: 21189395
Drug: Anthracycline-containing chemotherapy
RxNorm normalized name: methacycline
DrugBank: Metacycline (DB00931)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anthracycline-containing chemotherapy
Trial: 31916660
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of prolonged exposure and sertraline
Trial: 25509730
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of loratadine and nasal spray of budesonide
Trial: 8736270
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) therapy (2.0 IU/m2 per day)
Trial: 1704985
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of nitrendipine and cilazapril
Trial: 23953493
Drug: Milnacipran (≥100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milnacipran (≥100 mg/day)
Trial: 21421726
Drug: SB-773812 100
RxNorm normalized name: SB-773812
DrugBank: SB-773812 (DB16042)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-773812 100 mg/d
Trial: 15534128
Drug: 2% pirenzepine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2% pirenzepine ophthalmic gel
Trial: 29566659
Drug: Low-dose, high-frequency
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose, high-frequency (LDHF) training approach
Trial: 28270187
Drug: HICS treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HICS treatment
Trial: 16520570
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg of ketamine administered after induction of anesthesia, approximately 5 min prior to surgery
Trial: 16520570
Drug: 0.3 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.3 mg/kg of ketamine
Trial: 12697866
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human keratinocyte growth factor (KGF) at doses of 60 and 80 microg/kg/d
Trial: 11063766
Drug: Nifedipine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (10 mg orally, 3 times a day) during gentamicin therapy
Trial: 30837403
Drug: Hot-etching solution
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hot-etching solution (Group C)
Trial: 30837403
Drug: Non-treatment zirconia
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment zirconia (Group D)
Trial: 30837403
Drug: Non-treatment nickel-chromium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-treatment nickel-chromium alloy (Group E)
Trial: 22023910
Drug: Experimental food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental food preparers attended 8 weekly interactive lessons
Trial: 22023910
Drug: Control food
RxNorm normalized name: ALLERGENIC EXTRACT, FOOD, WHEAT
DrugBank: Wheat (DB10579)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control food preparers received 8 weekly mailings with similar recipes and handouts
Trial: 9101094
Drug: Continuous dobutamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous dobutamine infusion (6 micrograms/kg/min from 10 minutes before induction of anaesthesia till the fifth postoperative hour)
Trial: 8942578
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no dobutamine infusion)
Trial: 29843811
Drug: DCVax-L
RxNorm normalized name: DCVax-L
DrugBank: DCVax-L (DB17580)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DCVax-L
Trial: 23722616
Drug: QVA149 (indacaterol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QVA149 (indacaterol 110 μg/glycopyrronium 50 μg)
Trial: 11565519
Drug: Irbesartan 300
RxNorm normalized name: irbesartan 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Irbesartan 300 mg daily
Trial: 16505409
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 400 mg intramuscularly (single dose)
Trial: 16505409
Drug: Venlafaxine 37.5
RxNorm normalized name: venlafaxine 37.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine 37.5 mg per day for one week, then 75 mg per day
Trial: 10871979
Drug: Slow titration
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow titration (every 6 weeks)
Trial: 9201043
Drug: Dobutamine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dobutamine (5 to 200 micrograms/kg/min) administered to increase cardiac index and DO2 until all therapeutic goals were achieved.
Trial: 9201043
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received dobutamine only if cardiac index was < 2.8 L/min/m2.
Trial: 24904785
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg metoprolol on the day of surgery
Trial: 28748625
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment arms combined
Trial: 18580181
Drug: Lidocaine 1%
RxNorm normalized name: LIDOCAINE 1% LOTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine 1% with a 1.5 mg/kg intravenous bolus in 10 min followed by a 1.5 mg . kg . h intravenous infusion
Trial: 16086467
Drug: Conventional Medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional Medicine (CM) interventions
Trial: 16086467
Drug: Complementary and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Complementary and Alternative Medicine (CAM) interventions
Trial: 12461659
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of azathioprine and prednisone (NoCsA group, n=58)
Trial: 23561637
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D supplementation at a dose of 1000 U/day for 12 months
Trial: 21388579
Drug: Rivastigmine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivastigmine (3 mg twice a day, for 8 weeks)
Trial: 21388579
Drug: Rehabilitation treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rehabilitation treatment only (No-RIV)
Trial: 27702807
Drug: 1.25% fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25% fluoride gel
Trial: 18663301
Drug: 0.5% fluoride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5% fluoride gel
Trial: 9009677
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg bid for 14 days/amoxycillin 1000 mg bid for 14 days/tinidazole 500 mg bid for 14 days (Group A)
Trial: 9009677
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg bid for 14 days/amoxycillin 1000 mg bid for 14 days (Group B)
Trial: 9009677
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg bid for 14 days/azithromycin 500 mg/day for 3 days for 2 consecutive weeks (Group C)
Trial: 10583349
Drug: Ondansetron 16
RxNorm normalized name: ondansetron 16 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 16 mg
Trial: 6828338
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) 600 mg
Trial: 19361739
Drug: Acetaminophen 600
RxNorm normalized name: acetaminophen 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen 600 mg
Trial: 22392934
Drug: No neoadjuvant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No neoadjuvant therapy (Control)
Trial: 21969009
Drug: Chlorthalidone (12.5-25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (12.5-25 mg/d)
Trial: 19158191
Drug: Spironolactone (50-75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone (50-75 mg/d)
Trial: 17229249
Drug: Metformin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin plus pioglitazone
Trial: 9779521
Drug: Pergolide 0.25
RxNorm normalized name: pergolide 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pergolide 0.25 mg at bedtime
Trial: 8018978
Drug: Nizatidine 150
RxNorm normalized name: nizatidine 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nizatidine 150 mg/day
Trial: 7863254
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no regular treatment)
Trial: 2511913
Drug: sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual nitroglycerin tablets
Trial: 2511913
Drug: quickly dissolving
FDA approved: no
EMA approved: no
PMDA approved: no
Description: quickly dissolving nitroglycerin compound
Trial: 28301428
Drug: Adalimumab (ADA)
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab (ADA) treatment, open-label induction at weeks 0 and 2 by body weight (≥40 kg: 160 mg and 80 mg; <40 kg: 80 mg and 40 mg), followed by randomized double-blind dosing (high or low dose every other week) to week 52.
Trial: 22136978
Drug: Amlodipine/losartan 5/50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine/losartan 5/50 mg fixed-dose combination
Trial: 15277147
Drug: Fat plus
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fat plus 50 g sodium caseinate
Trial: 15277147
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of fat, oligosaccharides, and casein
Trial: 11382108
Drug: Early postoperative
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early postoperative oral feeding
Trial: 2521699
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (3 mg/kg/wk)
Trial: 124247
Drug: 1% spray
RxNorm normalized name: CLOTRIMAZOLE 1% SPRAY,TOP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% spray solution
Trial: 124247
Drug: 1% solution
RxNorm normalized name: GUMSOL 5%-0.01% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% solution
Trial: 25487613
Drug: Droxidopa (100-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Droxidopa (100-600 mg thrice-daily)
Trial: 11699314
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 0.5% timolol plus 2% dorzolamide (n = 22)
Trial: 31533578
Drug: Intrauterine device,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrauterine device, sterilisation, or oral contraceptives
Trial: 31533578
Drug: Contraceptive discontinuation
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive discontinuation
Trial: 23664773
Drug: IV ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV ketamine 0.5 mg/kg
Trial: 21241489
Drug: Drotrecogin alfa
RxNorm normalized name: Drotrecogin Alfa
DrugBank: Drotrecogin alfa (DB00055)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drotrecogin alfa (activated) (DAA) at doses of 6, 12, 18, or 24 μg/kg/hour
Trial: 21241489
Drug: Enoxaparin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin (1 mg/kg body weight twice daily)
Trial: 12691509
Drug: Dianeal PD‐4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dianeal PD‐4 containing 0.1 g/L HA
Trial: 1557981
Drug: Heparin surface
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin surface modified (HSM) intraocular lenses (IOLs)
Trial: 23139373
Drug: Exenatide 10
RxNorm normalized name: EXENATIDE 10MCG/DOSE 2.4ML 60D PEN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide 10 µg twice daily
Trial: 10353581
Drug: Subcutaneous immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous immunotherapy
Trial: 27770809
Drug: Active placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active placebo (benztropine mesylate, 1 mg)
Trial: 31043657
Drug: Burdock tea
RxNorm normalized name: BURDOCK
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Burdock tea (1.5 g three times a day)
Trial: 17290043
Drug: Infliximab (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infliximab (both doses)
Trial: 10859289
Drug: L-5-methyltetrahydrofolate (MTHF)
RxNorm normalized name: L-5-methyltetrahydrofolate
DrugBank: Levomefolic acid (DB11256)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: L-5-methyltetrahydrofolate (MTHF) at 17 mg/d
Trial: 8244149
Drug: Chemotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy with 5-epidoxorubicin emulsified in lipiodol
Trial: 28961427
Drug: Diclofenac potassium
RxNorm normalized name: Diclofenac Potassium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac potassium (50 mg)
Trial: 28251224
Drug: Paracetamol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol (1 gram)
Trial: 14678340
Drug: Duloxetine 40
RxNorm normalized name: duloxetine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 40 mg oral dose
Trial: 15184278
Drug: Duloxetine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine (various doses)
Trial: 11822006
Drug: Omeprazole as
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole as an adjunct to endoscopic intervention
Trial: 8577182
Drug: D‐methamphetamine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D‐methamphetamine (30 mg/70 kg) administered at 2130 h
Trial: 8577182
Drug: D‐methamphetamine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D‐methamphetamine (30 mg/70 kg)
Trial: 39574
Drug: 0.50 mg
RxNorm normalized name: EVEROLIMUS 0.50 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.50 mg MJ-9184-1
Trial: 9137792
Drug: TBI +
RxNorm normalized name: TBI-223
DrugBank: TBI-223 (DB18911)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TBI + melphalan 140 mg/m2
Trial: 9137792
Drug: melphalan 200
RxNorm normalized name: Melphalan
DrugBank: Melphalan (DB01042)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: melphalan 200 mg/m2
Trial: 23534323
Drug: Xylitol chewing
RxNorm normalized name: xylitol Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Xylitol chewing gum treatment (3 times/day for 3 months)
Trial: 15679251
Drug: Adjuvant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant treatment strategies